# OnCo record andrew-roberts (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/andrew-roberts/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "andrew-roberts" ;
  schema:name "Andrew Roberts"@en ;
  schema:alternateName "Andrew W. Roberts"@en, "Roberts AW"@en ;
  schema:description "A Melbourne haematologist who led the first human study of venetoclax, the leukaemia drug that grew from the Walter and Eliza Hall Institute's discovery that BCL-2 keeps cancer cells alive."@en ;
  schema:url <https://onco.cc/people/andrew-roberts/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1513257>, <https://www.wehi.edu.au/news/anti-cancer-treatment-venetoclax-listed-australian-pbs/> ;
  schema:jobTitle "Haematologist and researcher, Walter and Eliza Hall Institute of Medical Research" ;
  onco:related <https://onco.cc/institutions/peter-mac/> ;
  onco:cancers <https://onco.cc/cancers/cll/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/> ;
  onco:institutions <https://onco.cc/institutions/wehi/> ;
  onco:people <https://onco.cc/people/john-seymour/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-roberts-venetoclax-relapsed-cll-nejm-2016/> ;
  schema:affiliation <https://onco.cc/institutions/wehi/> .
